CYP19A1 and breast cancer: Each of the cell lines had been extensively cultured in the absence of exogeneous E2 to generate long-term estrogen-deprived (LTED) lines that proliferate in an E2-independent manner thus modeling breast cancer that has become resistant to aromatase inhibitor therapy (see Supplementary Methods; Supplementary Fig. S1).